Kyntra Bio (KYNB) Gross Margin Growth (3y) (2021 - 2026)
Kyntra Bio (KYNB) Gross Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14,836.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 589.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 53.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,244.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 569.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Kyntra Bio | 30.42 Mn | 30.42 Mn | 1.47 Mn | 3,950.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,950.00 |
| Mar 31, 2026 | 9,551.00 |
| Dec 31, 2025 | 3,686.00 |
| Sep 30, 2025 | 2,199.00 |
| Jun 30, 2025 | 1,654.00 |
| Mar 31, 2025 | 3,404.00 |
| Dec 31, 2024 | 20,537.00 |
| Sep 30, 2024 | -5,888.00 |
| Jun 30, 2024 | -2,237.00 |
| Mar 31, 2024 | -87,407.00 |
| Dec 31, 2023 | -882.00 |
| Sep 30, 2023 | -556.00 |
| Jun 30, 2023 | -213.00 |
| Mar 31, 2023 | -20,138.00 |
| Dec 31, 2022 | -4,728.00 |
| Sep 30, 2022 | -2,665.00 |
| Jun 30, 2022 | -2,284.00 |
| Mar 31, 2022 | -4,324.00 |
| Dec 31, 2021 | -1,889.00 |
| Sep 30, 2021 | -209.00 |